Haleon recognised among global sustainability leaders

7 February 2024: Haleon, a global leader in consumer health, today announced that it has been recognised by S&P for excellent sustainability performance and added to the Dow Jones Sustainability Index Europe (DJSI) 2023.

The group scored in the top decile in the Personal Products Industry in Europe as of 1 February, 2024.Haleon was also added to S&P’s 2024 Global Sustainability Yearbook, a distinction intended to highlight top performers within the index.

This is a milestone achievement for Haleon, with the DJSI – a leading global sustainability benchmark for the investor community – recognising the company’s leadership as a responsible organisation during its first full calendar year as a standalone business.

Haleon’s membership of DJSI Europe and inclusion in their Global Sustainability Yearbook demonstrates the company’s ongoing commitment to responsible business practices and transparency on its sustainability efforts.

Sarah McDonald, VP Sustainability, Haleon, said: “It’s great to see the work we’ve done over the past year recognised by the S&P. As a global leader in consumer health, Haleon is well-positioned to help address the environmental and social barriers which hold people back from better everyday health. Being a responsible business is an essential pillar of our strategy and we take seriously the value it creates for our business and all our stakeholders. We’re proud to be included in the 2024 Dow Jones Global Sustainability Yearbook but recognise that we have more work to do and are looking forward to making further progress in the year ahead.”

Haleon’s sustainability strategy is underpinned by three key ambitions:

Making everyday health more inclusive. By 2025 Haleon aims to empower 50 million people a year to be more included in opportunities for better everyday health. The group is working to drive change through its purposeful brands, for instance the Advil Pain Equity Project which champions equitable and accessible pain relief in the USA. It’s also investing in research and action, such as supporting Economist Impact’s Health Inclusivity Index to identify barriers to heath inclusion.

Reducing its environmental impact. That includes its aim to achieve Net Zero carbon emissions from source to sale by 2040 (aligned to guidance from The Climate Pledge and Race to Zero)^[1]. Haleon is also aiming to make packaging more sustainable, to sustainably source trusted ingredients and to integrate water stewardship and waste circularity into its operations. Haleon hit some major milestones on its journey to reduce environmental impact in 2023 including the achievement of its first water neutral site in Cape Town, South Africa.

Operating with ethical and responsible standards. Haleon is committed to acting with honesty, transparency and integrity and aims to work with third parties that share this commitment. Haleon wove these commitments throughout the business in 2023 with several initiatives. For example, with the launch of an ESG expectations document, which outlines the environmental, social and governance targets Haleon has set for suppliers.

Ends

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com